ROSSO-in-praxi-international: Long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin

Diabetes Technology and Therapeutics

Volumn 15, Issue 1, 2013, Pages 89-96

  Kempf, Kerstin ^a   Tankova, Tsvetalina ^b   Martin, Stephan ^a  

^a Dusseldorf Catholic Hospital Group   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF MONITORING; TREATMENT RESPONSE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BULGARIA; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; TIME; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872171678     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0213     Document Type: Article

References (15)

1. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ: Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: One-year results of the look AHEAD trial. Diabetes Care 2007;30:1374-1383 (Pubitemid 46871141)
2. Clinical Guidelines Task Force: Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005
3. Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM: Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care 2003;26:36-47 (Pubitemid 36928992)
4. National Institute for Health and Clincal Excellence: Quick Reference Guide Type 2 Diabetes. The Management of Type 2 Diabetes. London: National Health Service, 2008
5. International Diabetes Federation: Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes. Brussels: International Diabetes Federation, 2009
6. International Diabetes Federation: Guideline for Management of Postmeal Glucose. Brussels: International Diabetes Federation, 2007
7. Kempf K, Kruse J, Martin S: ROSSO-in-praxi: A selfmonitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther 2010;12:547-553
8. Kempf K, Kruse J, Martin S: ROSSO-in-praxi follow-up: Long-term effects of self-monitoring of blood glucose on weight, hemoglobin A1c, and quality of life in patients with type 2 diabetes mellitus. Diabetes Technol Ther 2012; 14:59-64
9. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA: Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: An epidemiological cohort study. Diabetologia 2006;49:271-278 (Pubitemid 43185395)
10. The International SMBG Working Group: Self-monitoring of blood glucose in type 2 diabetes: Steps toward consensus. Diabetes Care 2007;30:e105
11. Kempf K, Neukirchen W, Martin S, Kolb H: Self-monitoring of blood glucose in type 2 diabetes: A new look at published trials. Diabetologia 2008;51:686-688
12. Schwedes U, Siebolds M, Mertes G: Meal-related structured self-monitoring of blood glucose: Effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002;25:1928-1932 (Pubitemid 41071046)
13. Allemann S, Houriet C, Diem P, Stettler C: Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: A systematic review and meta-analysis. Curr Med Res Opin 2009;25:2903-2913
14. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
15. Schneider B, Martin S, Heinemann L, Lodwig V, Kolb H: Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes: Results of a longitudinal cohort study (ROSSO 5). Arzneimittelforschung 2007;57:762-769